For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Regimen A (VAC/VI) | Patients receive vincristine sulfate IV over 1 minute on day 1 of weeks 1-13, 16, 17, 19, 20, 22-26, 28, 31-34, 37, 38, and 40, dactinomycin IV over 1-5 or 10-15 minutes on day 1 of weeks 1, 7, 13, 22, 28, 34, and 40, cyclophosphamide IV over 60 minutes on day 1 of weeks 1, 7, 13, 22, 28, 34, and 40, irinotecan hydrochloride IV over 90 minutes on days 1-5 of weeks 4, 10, 16, 19, 25, 31, and 37. Patients also undergo primary site RT beginning at week 13 or metastatic site RT beginning at week 43 for up to 6.5 weeks. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients then receive vinorelbine IV over 6-10 minutes on days 1, 8, and 15 and cyclophosphamide PO QD on days 1-28. Cycles repeats every 28 days for 24 weeks in the absence of disease progression or unacceptable toxicity. | 33 | None | 17 | 155 | 139 | 155 | View |
| Regimen B (VAC/VI/Temsirolimus) | Patients receive vincristine sulfate IV over 1 minute on day 1 of weeks 1-13, 16, 17, 19, 20, 22-26, 28, 31-34, 37, 38, and 40, dactinomycin IV over 1-5 or 10-15 minutes on day 1 of weeks 1, 7, 13, 22, 28, 34, and 40, cyclophosphamide IV over 60 minutes on day 1 of weeks 1, 7, 13, 22, 28, 34, and 40, irinotecan hydrochloride IV over 90 minutes on days 1-5 of weeks 4, 10, 16, 19, 25, 31, and 37 and temsirolimus IV over 30-60 minutes on day 1 of weeks 1-12 and 21-42. Patients also undergo RT as in Regimen A. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients then receive vinorelbine IV over 6-10 minutes on days 1, 8, and 15 and cyclophosphamide PO QD on days 1-28. Cycles repeats every 28 days for 24 weeks in the absence of disease progression or unacceptable toxicity. | 33 | None | 77 | 153 | 141 | 153 | View |
| Regimen C (FOXO1 Fusion Negative, VAC/VA) | Patients receive vincristine sulfate IV over 1 minute on day 1 of weeks 1-10 and 13-22, dactinomycin IV over 1-5 or 10-15 minutes on day 1 of weeks 1, 4, 7, 10, 13, 16, 19, and 22, cyclophosphamide IV over 60 minutes on day 1 of weeks 1, 4, 7, and 10. Patients undergo RT beginning at week 13 for up to 6.5 weeks. Treatment continues in the absence of disease progression or unacceptable toxicity. | 0 | None | 0 | 3 | 1 | 3 | View |
| Feasibility (VAC/VI/Temsirolimus) | Patients receive vincristine sulfate IV over 1 minute on day 1 of weeks 1-13, 16, 17, 19, 20, 22-26, 28, 31-34, 37, 38, and 40, dactinomycin IV over 1-5 or 10-15 minutes on day 1 of weeks 1, 7, 13, 22, 28, 34, and 40, cyclophosphamide IV over 60 minutes on day 1 of weeks 1, 7, 13, 22, 28, 34, and 40, irinotecan hydrochloride IV over 90 minutes on days 1-5 of weeks 4, 10, 16, 19, 25, 31, and 37 and temsirolimus IV over 30-60 minutes on day 1 of weeks 1-12 and 21-42. Patients also undergo RT as in Regimen A. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients then receive vinorelbine IV over 6-10 minutes on days 1, 8, and 15 and cyclophosphamide PO QD on days 1-28. Cycles repeats every 28 days for 24 weeks in the absence of disease progression or unacceptable toxicity. | 4 | None | 6 | 10 | 8 | 10 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Bladder spasm | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Eye disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Flu like symptoms | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Gait disturbance | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Gastric hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Gastric ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Gastrointestinal disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Hematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Hypertriglyceridemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypoglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Ileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Respiratory failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Serum amylase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Sinus bradycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Appendicitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Abdominal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Allergic reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv5 | View |
| Anal mucositis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Anaphylaxis | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv5 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Anorectal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Catheter related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Cecal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Colonic obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Cystitis noninfective | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Cytokine release syndrome | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv5 | View |
| Death NOS | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Dermatitis radiation | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Disease progression | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Ear and labyrinth disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv5 | View |
| Enterocolitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Enterocolitis infectious | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Infections and infestations - Other, specify | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Infusion related reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Lethargy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Lung infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Mucositis oral | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Pancreatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Pharyngeal mucositis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Pneumonitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Rectal fistula | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Sinusoidal obstruction syndrome | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | CTCv5 | View |
| Skin and subcutaneous tissue disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Small intestinal obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Thromboembolic event | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Tumor hemorrhage | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CTCv5 | View |
| Typhlitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Upper gastrointestinal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Upper respiratory infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Urinary retention | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Urinary tract obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Urinary tract pain | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Ventricular tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Weight loss | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal distension | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Abdominal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Agitation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Alkaline phosphatase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Alkalosis | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Allergic reaction | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv5 | View |
| Allergic rhinitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Anal fissure | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Anal mucositis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Anal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Anaphylaxis | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv5 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Anorectal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Apnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Ascites | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Aspiration | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Atelectasis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Bacteremia | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Bladder infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Bladder spasm | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Blurred vision | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Bone pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Bronchial infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Bruising | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Burn | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Catheter related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Cholesterol high | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Cognitive disturbance | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Colonic obstruction | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Colonic perforation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Confusion | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Conjunctivitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Conjunctivitis infective | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Corneal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Cystitis noninfective | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Delirium | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Dermatitis radiation | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Device related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Disease progression | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Dysgeusia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Dyspepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Dysphagia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Ear and labyrinth disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv5 | View |
| Ear pain | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv5 | View |
| Eczema | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Edema face | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Edema limbs | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Ejection fraction decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Electrocardiogram QT corrected interval prolonged | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Encephalitis infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Enterocolitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Enterocolitis infectious | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Erythema multiforme | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Extraocular muscle paresis | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Eye disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Eye infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Eye pain | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Eyelid function disorder | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Facial pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Fecal incontinence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Flank pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Folliculitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Fungemia | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| GGT increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Gallbladder obstruction | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | CTCv5 | View |
| Gastric hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Gastroesophageal reflux disease | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Gastrointestinal disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| General disorders and administration site conditions - Other, specify | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Generalized muscle weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Genital edema | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Hallucinations | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Hearing impaired | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv5 | View |
| Hematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Hematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Hemorrhoids | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Herpes simplex reactivation | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Hiccups | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Hoarseness | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Hot flashes | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hyperhidrosis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hyperlipidemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypermagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hyperphosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypersomnia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Hypertriglyceridemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypoglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Ileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Immune system disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv5 | View |
| Infections and infestations - Other, specify | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Infusion related reaction | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Infusion site extravasation | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Injury, poisoning and procedural complications - Other, specify | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Irregular menstruation | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Irritability | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Kidney infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Large intestinal anastomotic leak | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Laryngeal edema | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Laryngeal hemorrhage | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Laryngeal inflammation | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Leukocytosis | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv5 | View |
| Lip infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Lung infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Lymphedema | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Lymphocyte count increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Malaise | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Meningitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Menorrhagia | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Middle ear inflammation | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv5 | View |
| Mucosal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Mucositis oral | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Muscle cramp | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Muscle weakness lower limb | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Nasal congestion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Neck edema | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Neck pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Nervous system disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Neuralgia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Oculomotor nerve disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Optic nerve disorder | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Oral pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Otitis externa | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Otitis media | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCv5 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Pain of skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Pancreatitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Papilledema | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Papulopustular rash | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Paresthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Paronychia | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Pelvic pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Penile pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Perineal pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Periorbital edema | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv5 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Peritoneal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Personality change | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Phantom pain | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Pharyngeal mucositis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Pharyngeal stenosis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Pharyngitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Pneumothorax | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Presyncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Proctitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Productive cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Psychiatric disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Pulmonary edema | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Radiation recall reaction (dermatologic) | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Rash acneiform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Rash maculo-papular | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Rash pustular | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Rectal fissure | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Rectal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Renal and urinary disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Renal calculi | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Reproductive system and breast disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Respiratory failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Rhinitis infective | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Rhinorrhea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Salivary gland infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Seroma | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Sinus bradycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Skin and subcutaneous tissue disorders - Other, specify | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Skin infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Sleep apnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Small intestinal mucositis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Social circumstances - Other, specify | SYSTEMATIC_ASSESSMENT | Social circumstances | CTCv5 | View |
| Somnolence | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Sore throat | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Stomach pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Stridor | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Suicidal ideation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv5 | View |
| Superficial thrombophlebitis | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Supraventricular tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv5 | View |
| Surgical and medical procedures - Other, specify | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | CTCv5 | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Tendon reflex decreased | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv5 | View |
| Thromboembolic event | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv5 | View |
| Thrush | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Trismus | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv5 | View |
| Tumor lysis syndrome | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv5 | View |
| Tumor pain | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CTCv5 | View |
| Typhlitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Upper respiratory infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Urinary frequency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Urinary incontinence | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Urinary retention | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |
| Urinary tract obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Urinary tract pain | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv5 | View |
| Urostomy stenosis | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Urticaria | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv5 | View |
| Vaginal pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv5 | View |
| Vascular access complication | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Voice alteration | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv5 | View |
| Weight gain | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Weight loss | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Wheezing | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv5 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv5 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv5 | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv5 | View |